Search Results - "Yoshida, C.F.T."

635 USEFULNESS OF DRIED BLOOD SPOTS FOR HEPATITIS B VIRUS DIAGNOSIS by Villar, L.M, de Oliveira, J.C, Medina, H, Yoshida, C.F.T, Lampe, E, Lewis-Ximenez, L.L

Get full text

634 SALIVA AS A SOURCE FOR HEPATITIS B VIRUS DIAGNOSIS by Villar, L.M, Medina, H, Villela-Nogueira, C.A, Nabuco, L.C, Rodrigues do Ó, K.M, da Silva, E.F, Lewis-Ximenez, L.L, Yoshida, C.F.T, Lampe, E

Get full text

Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis by Espírito-Santo, M P, Carneiro, M A S, Reis, N R S, Kozlowski, A G, Teles, S A, Lampe, E, Yoshida, C F T, Martins, R M B

“…The present study examined the distribution of hepatitis C virus (HCV) genotypes and subtypes in a hemodialysis population in Goiás State, Central Brazil, and…”
Get full text

Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil by Oliveira, M L, Bastos, F I, Telles, P R, Yoshida, C F, Schatzmayr, H G, Paetzold, U, Pauli, G, Schreier, E

“…Viral hepatitis constitutes a major health issue, with high prevalence among injecting drug users (IDUs). The present study assessed the prevalence and risk…”
Get full text

Distribution of HCV genotypes among different exposure categories in Brazil by Oliveira, M L, Bastos, F I, Sabino, R R, Paetzold, U, Schreier, E, Pauli, G, Yoshida, C F

“…Hepatitis C virus (HCV) infection is widespread and responsible for more than 60% of chronic hepatitis cases. HCV presents a genetic variability which has led…”
Get full text

Genomic characterization of Brazilian hepatitis C virus genotypes 1a and 1b by Ginabreda, M G, Yoshida, C F, Niel, C

“…Parts of 5' non-coding (5' NC) and of E1 envelope regions of the hepatitis C virus (HCV) genome were amplified from sera of 26 Brazilian anti-HCV…”
Get full text

The use of non-human primates as animal models for the study of hepatitis viruses by Vitral, C L, Yoshida, C F, Gaspar, A M

“…Hepatitis viruses belong to different families and have in common a striking hepatotropism and restrictions for propagation in cell culture. The…”
Get full text

Prevalence of hepatitis C antibodies among health care workers at high risk for blood exposure by Martins, R M, Almeida, V C, Vanderborght, B O, Brito, J B, Cardoso, D D, Pereira, M S, Yoshida, C F

Get full text

High proportion of subgroup A' (genotype A) among Brazilian isolates of Hepatitis B virus by Araujo, N.M, Mello, F.C.A, Yoshida, C.F.T, Niel, C, Gomes, S.A

“…Hepatitis B virus (HBV) genotype A has been divided recently into two subgroups, designated A-A' (genotype A excluding A') and A'. Isolates belonging to…”
Get full text

P.480 High prevalence of genotype 2c hepatitis C virus in Córdoba, Argentina by Ré, V., Contigiana, M., Yoshida, C.F.T., Lampe, E.

Get full text

P.478 Nosocomial transmission of hepatitis C virus infection in hemodialysis patients in Brazil: phylogenetic evidence by Lampe, E., Carneiro, M.A.S., Espírito-Santo, M.P., Gouveia-Oliveira, R., Yoshida, C.F.T., Martins, R.M.B.

Get full text

P.348 Comparative evaluation of three different commercial assays for quantitation of anti-HBs levels after immunization with recombinant vaccines by Miguel, J.C., Oliveira, M.L.A., Camacho, L.A.B., Yoshida, C.F.T., Do Ó, K.M.R., Martins, R.M.

Get full text

P.499 Declining prevalence of HCV infection among injection drug users from Rio de Janeiro, Brazil: a comparative analysis of two cross-sectional surveys by Oliveira, M.L.A., Telles, P.R., Oliveira, S.A.N., Miguel, J.C., Yoshida, C.F.T., Do Ó, K.M.R., Bastos, F.I.

Get full text

P.500 “The first shot”: the context of first injection of illicit drugs, ongoing injecting practices and hepatitis C virus (HCV) infection by Oliveira, M.L.A., Hacker, M., Oliveira, S.A.N., Do Ó, K.R., Yoshida, C.F.T., Telles, P., Bastos, F.I.

Get full text

P.297 Three cases of acute hepatitis C virus infection following dry sex by Lewis-Ximenez, L.L., Espírito-Santo, M.P., Oliveira, J.M., Lauer, G., Walker, B., Yoshida, C.F.T., Lampe, E.

Get full text

P.457 Risk behaviors and hepatitis C virus (HCV) infection among new- and long-term injection drug users (IDUs) by Oliveira, M.L.A., Oliveira, S.A.N., Telles, P.R., Hacker, M., Miguel, J.C., Do Ó, K.M.R., Yoshida, C.F.T., Bastos, F.I.

Get full text

Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection by Lewis-Ximenez, L L, Oliveira, J M, Mercadante, L A, De Castro, L, Santa Catharina, W, Stuver, S, Yoshida, C F

“…During an outbreak of hepatitis B virus (HBV) infection in a hemodialysis unit, patients were assessed for serological viral markers and vaccination status…”
Get more information

Immunogenicity of a Recombinant Hepatitis B Vaccine (Euvax-B) in Haemodialysis Patients and Staff by Teles, S. A., Martins, R. M. B., Lopes, C. L. R., M. A. dos Santos Carneiro, Souza, K. P., Yoshida, C. F. T.

“…Hepatitis B vaccine is the most effective strategy for preventing the transmission of hepatitis B virus (HBV) in haemodialysis centers. Nevertheless, lower…”
Get full text

Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients Anticorpos contra os antígenos não estrutural c100/3 e estrutural core do vírus da hepatite C (HCV) em pacientes de hemodiálise by C.F.T. Yoshida, Y. Takahashi, B.O.M. Vanderborght, C.D. Rouzere, M.S. França, C. Takahashi, A. Takamizawa, I. Yoshida, H.G. Schatzmayr

“…Two groups of patients undergoing hemodialysis (HD) maintenance were evaluated for their antibody response to non-structural c100/3 protein and structural core…”
Get full text

Immunization aganist hepatitis B in children from endemic zone: evaluation of the antibody response against the DNA recombinant vaccine (Engerix B-20 mcg) by Ferreira, C.R.B., Yoshida, C.F.T., Mercadante, L.A.C., Gomes, D.F., Oliveira, J.M., França, M.S., Sidoni, M., Ennes, I.C., Baptista, M.L., Schatzmayr, H.G., Gaspar, A.M.C.

“…A previous seroepidemiological study in the rural zone of Vargem Alta (ES) SouthEast of Brazil, showed a prevalence of up to 9% of hepatitis B surface antigen…”
Get full text